Fractyl Health, Inc. (GUTS) vs iBio, Inc. (IBIO)

Fractyl Health, Inc. and iBio, Inc. are both Biotechnology companies. Fractyl Health, Inc. and iBio, Inc. are of similar size ($77.3M and $76.4M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −66.6%. Across the 12 metrics below, iBio, Inc. leads on 8 and Fractyl Health, Inc. on 4.

Valuation

Metric GUTS IBIO Biotechnology median
P/E n/m n/m 7.88
P/S 835.89 183.45 11.47
P/B n/m 1.44 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 656.39 55.05 10.73
Earnings yield (179.59%) (28.57%) (28.84%)
Free cash flow yield (106.75%) (19.57%) (23.03%)

Profitability

Metric GUTS IBIO Biotechnology median
Gross margin 46.24% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% (65.70%) (57.72%)
Return on assets (146.75%) (54.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS IBIO Biotechnology median
Revenue growth (TTM) (22.50%) (66.55%) 5.64%
EPS growth (last fiscal year) (14.81%) 81.71% —
Revenue growth, 5-year CAGR — (42.83%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS IBIO Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 7.85 4.73
Net debt to EBITDA 0.53 2.57 0.96

Dividend

Metric GUTS IBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric GUTS IBIO Biotechnology median
Market cap 76.41m 77.28m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack